Synaptiq
PrivateLast Round
Late Seed
Jul 6, 2026
Est. Valuation
$5.85M
Total Funding Raised
$1.26M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Synaptiq operates in Healthcare & Life Sciences and is based in Cluj-Napoca. Its latest recorded funding round was an Accelerator round in April 2026.
Synaptiq is a healthcare technology company that develops AI-powered software to automate the contouring of tumors and organs at risk for radiotherapy treatment planning.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synaptiq Comparables
Compare Synaptiq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MVision AI | 89% | |
| TheraPanacea | 88% | |
| Oncosoft | 86% |
For institutional investors. Book with your work email.
Synaptiq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Late Seed | Jul 6, 2026 | ||||
| Accelerator | Apr 23, 2026 | ||||
| Grant | Dec 20, 2023 | ||||
| Seed | Apr 4, 2023 | ||||
| Grant | Aug 29, 2022 | ||||
Pre Seed | Oct 19, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synaptiq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Accelerator |
| GapMinder Venture Partners | Pre Seed |
| Cleverage Venture Capital | Pre Seed, Seed |
| Fortech Investments | Seed |
| Innovasjon Norge | Grant |
| Cleverage Venture Capital | Pre Seed, Seed |
| SeedBlink | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 81% MoM, from 3.4K to 6.2K.
- Jul 25, 2026
Monthly visitors increased 149% MoM.
For institutional investors. Book with your work email.
Synaptiq Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synaptiq's valuation, stock price, and market status.
Is Synaptiq a public or private company?
Synaptiq is a private company.
What is the current stock price of Synaptiq?
Synaptiq is a private company, so its shares have no public market price. Caplight tracks Synaptiq's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synaptiq worth (valuation)?
Synaptiq's valuation is estimated at $5.8M based on funding round data.
Can I buy Synaptiq stock?
Synaptiq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synaptiq's last funding round?
Synaptiq's most recent funding round was Late Seed on July 6, 2026.
Who are the main investors in Synaptiq?
Key investors in Synaptiq include Fortech Investments.
Will Synaptiq IPO soon?
No public IPO plans have been announced for Synaptiq.
How can I track Synaptiq secondary market activity?
Caplight tracks bids, offers, and trades in Synaptiq's shares on secondary markets.